标题
Metaplastic Breast Cancer: Current Understanding and Future Directions
作者
关键词
-
出版物
Clinical Breast Cancer
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-04-19
DOI
10.1016/j.clbc.2023.04.004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes
- (2022) Waqar Haque et al. Clinical Breast Cancer
- Histological subtype is associated with PD-L1 expression and CD8+ T-cell infiltrates in triple-negative breast carcinoma
- (2022) Taylor Salisbury et al. Annals of Diagnostic Pathology
- Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
- (2022) Clinton Yam et al. CLINICAL CANCER RESEARCH
- Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders
- (2022) M Dooms et al. Frontiers in Pharmacology
- Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
- (2022) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metaplastic Carcinoma of the Breast: MRI Features with Clinical and Histopathologic Correlation
- (2022) Siqi Wang et al. ACADEMIC RADIOLOGY
- Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer
- (2022) Renata Colombo Bonadio et al. Clinical Breast Cancer
- Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma
- (2022) Qing-cong Kong et al. Frontiers in Oncology
- TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas
- (2022) Suzanne Chartier et al. HISTOPATHOLOGY
- Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype
- (2021) Audree B. Tadros et al. ANNALS OF SURGICAL ONCOLOGY
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- (2021) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US
- (2021) Elizabeth B. Elimimian et al. JAMA Network Open
- PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays
- (2021) Anne Grabenstetter et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
- (2021) D. Trapani et al. BREAST CANCER RESEARCH AND TREATMENT
- Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
- (2021) Willard Wong et al. npj Breast Cancer
- Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
- (2021) Elan Gorshein et al. Case Reports in Oncology
- A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
- (2021) Sylvia Adams et al. CLINICAL CANCER RESEARCH
- Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
- (2020) Francesca Sanges et al. BMC CANCER
- Big Data Solutions for Controversies in Breast Cancer Treatment
- (2020) Adrienne N. Cobb et al. Clinical Breast Cancer
- Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
- (2020) Silvia González-Martínez et al. Cancers
- The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
- (2020) Lea Moukarzel et al. Molecular Oncology
- Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components
- (2020) Huang-Chun Lien et al. VIRCHOWS ARCHIV
- Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
- (2019) Zahraa Al-Hilli et al. BREAST CANCER RESEARCH AND TREATMENT
- Adjuvant Treatment of Triple Negative Metaplastic Breast Cancer with Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review from a Single Institution
- (2019) Natalie W. Harper et al. Clinical Breast Cancer
- Digital pathology and artificial intelligence
- (2019) Muhammad Khalid Khan Niazi et al. LANCET ONCOLOGY
- Implementation of Digital Pathology Offers Clinical and Operational Increase in Efficiency and Cost Savings
- (2019) Matthew G. Hanna et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant
- (2019) Jennifer K. Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database
- (2019) Yongfeng Li et al. Journal of Translational Medicine
- Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database
- (2018) Cecilia T. Ong et al. ANNALS OF SURGICAL ONCOLOGY
- Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis
- (2018) Matthew N. Mills et al. EUROPEAN JOURNAL OF CANCER
- Clinical trial methodology in rare gynecologic tumor research: Strategies for success
- (2018) Jubilee Brown et al. GYNECOLOGIC ONCOLOGY
- Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010–2014
- (2018) Mary C. Schroeder et al. ONCOLOGIST
- Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images
- (2018) Caglar Senaras et al. PLoS One
- Relationship between the Ki67 index and its area based approximation in breast cancer
- (2018) Muhammad Khalid Khan Niazi et al. BMC CANCER
- Does metaplastic breast carcinoma demonstrate a different clinicopathological behavior in our region: The Shiraz Breast Cancer Registry
- (2018) Majid Akrami et al. Breast Journal
- PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study
- (2018) Ming-Han Yang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer
- (2017) Reva K. Basho et al. JAMA Oncology
- A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
- (2016) Ashley Cimino-Mathews et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Whole exome sequencing of rare aggressive breast cancer histologies
- (2016) Maria Vittoria Dieci et al. BREAST CANCER RESEARCH AND TREATMENT
- Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases
- (2016) Fiona Langlands et al. BRITISH JOURNAL OF RADIOLOGY
- Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
- (2016) Upasana Joneja et al. JOURNAL OF CLINICAL PATHOLOGY
- The value of research collaborations and consortia in rare cancers
- (2016) Jean-Yves Blay et al. LANCET ONCOLOGY
- Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma
- (2016) Na Zhou et al. Oncotarget
- Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper
- (2014) P. G. Casali et al. ANNALS OF ONCOLOGY
- Hormone Receptor Status Does Not Affect Prognosis in Metaplastic Breast Cancer: A Population-Based Analysis with Comparison to Infiltrating Ductal and Lobular Carcinomas
- (2014) G. Paul Wright et al. ANNALS OF SURGICAL ONCOLOGY
- Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis
- (2014) Rebecca A. Nelson et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study
- (2014) E A Rakha et al. BRITISH JOURNAL OF CANCER
- Metastatic breast carcinomas display genomic and transcriptomic heterogeneity
- (2014) Britta Weigelt et al. MODERN PATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
- (2011) I. C. Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Computerized classification of intraductal breast lesions using histopathological images
- (2011) M. Murat Dundar et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started